Periodic Reporting for period 6 - IB4SD-TRISTAN (Imaging Biomarkers (IBs) for Safer Drugs: Validation of Translational Imaging Methods in Drug Safety Assessment - Sofia ref.: 116106)

Before new drugs are marketed, regulatory authorities must be satisfied that the benefits from the new drug outweigh any harms that might occur. The characterization and amelioration of potential harms is called Drug Safety Assessment.Biomarkers are important in Drug Safety...